Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
ATYR
Stock Latest News
Ratings
Confident Buy Rating for aTyr Pharma Amidst Promising Phase 3 Study Insights
6d ago
ATYR
Premium
The Fly
aTyr names Dalia Reyes head of commercial, global efzofitimod franchise
7d ago
ATYR
Premium
The Fly
aTyr Pharma director buys $15K in common stock
15d ago
ATYR
Premium
Market News
aTyr Pharma (ATYR) Stock Soars 24% on Promising Drug Developments
16d ago
ATYR
Premium
Ratings
Buy Rating Affirmed for aTyr Pharma Amid Strategic Trial Adjustments and Financial Stability
16d ago
ATYR
Premium
Company Announcements
aTyr Pharma’s Earnings Call Highlights Progress and Challenges
18d ago
ATYR
Premium
Ratings
Strategic Adjustments and Promising Developments Lead to Buy Rating for aTyr Pharma
19d ago
ATYR
Premium
Company Announcements
aTyr Pharma Reports 2024 Results and Strategic Progress
19d ago
ATYR
Premium
The Fly
aTyr Pharma reports Q4 EPS (18c), consensus (23c)
19d ago
ATYR
Premium
The Fly
aTyr Pharma publishes efzofitimod data in Science Translational Medicine
20d ago
ATYR
Premium
Ratings
aTyr Pharma: Attractive Buy Opportunity Amid Positive Phase 2 Data and Anticipated Phase 3 Catalysts
26d ago
ATYR
Premium
The Fly
aTyr Pharma announces DSMB recommendation for EFZO-FIT study to continue
26d ago
ATYR
Premium
Ratings
Positive Outlook on aTyr Pharma: Anticipated Catalysts and Risk-Reward Opportunities
1M ago
ATYR
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ALLO
ATYR
Premium
The Fly
aTyr Pharma initiated with an Outperform at Leerink
1M ago
ATYR
Premium
Ratings
Buy Rating on aTyr Pharma Driven by Promising Efzofitimod Phase 3 Study Prospects
1M ago
ATYR
Premium
The Fly
aTyr Pharma initiated with an Overweight at Cantor Fitzgerald
3M ago
ATYR
Premium
The Fly
aTyr Pharma appoints Eric Benevich to the company’s Board
4M ago
ATYR
Premium
The Fly
aTyr Pharma announces third positive DSMB review for efzofitimod
4M ago
ATYR
Premium
The Fly
aTyr Pharma to present preclinical research on ATYR0101 at symposia on Firbosis
4M ago
ATYR
Premium
The Fly
aTyr Pharma initiated with a Buy at Lucid Capital
4M ago
ATYR
Premium
Company Announcements
aTyr Pharma Reports Q3 2024 Financial Results
5M ago
ATYR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
